|
38768631 |
0 |
Roy DC, Wang TF, Lun R, et al.
Circulating Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis.
Thromb Haemost. 2024 May 20. doi: 10.1055/a-2330-1371.
|
|
38291601 |
0 |
Roy DC, Wang TF, Lun R, et al.
Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis.
Am J Hematol. 2024 Jan 30. doi: 10.1002/ajh.27222.
|
|
38087414 |
0 |
Uminski K, Xu Y, Zahrai A, et al.
Management strategies in persons with inherited haemophilia requiring antithrombotic therapy: A scoping review.
Haemophilia. 2023 Dec 12. doi: 10.1111/hae.14906.
|
|
36696186 |
0 |
Caiano LM, Drury T, Zahrai A, et al.
Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis.
J Thromb Haemost. 2022 Dec 22:S1538-7836(22)18246-2. doi: 10.1016/j.jtha.2022.12.008.
|
|
35468835 |
0 |
Lamb T, Lenet T, Zahrai A, et al.
Timing of pharmacologic venous thromboembolism prophylaxis initiation for trauma patients with nonoperatively managed blunt abdominal solid organ injury: a systematic review and meta-analysis.
World J Emerg Surg. 2022 Apr 25;17(1):19. doi: 10.1186/s13017-022-00423-1.
|
|
34742140 |
0 |
Nayak AL, Zahrai A, Mallick R, et al.
Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial.
Thromb Res. 2021 Oct 26;208:79-82. doi: 10.1016/j.thromres.2021.10.018.
|
, McMaster University